Jason A Zell1, Jane Honda, Argyrios Ziogas, Hoda Anton-Culver. 1. Chao Family Comprehensive Cancer Center, Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Irvine, CA 92697, USA. jzell@uci.edu
Abstract
BACKGROUND: Colorectal cancer (CRC) family history is a known risk factor for CRC development; however, effects of CRC family history on survival after CRC diagnosis are less well-defined. Our population-based analysis investigates whether familial CRC cases exhibit improved survival compared with sporadic CRC cases. METHODS: Cases enrolled in the University of California Irvine Gene-Environment Study of Familial Colorectal Cancer from 1994 to 1996 were analyzed, with follow-up through December 2006. Cases were categorized as familial or sporadic based on self-reported CRC family history in a first-degree relative. Univariate and multivariate survival analyses with Cox proportional hazards ratios were done for overall survival (OS) and CRC-SS (CRC-SS). RESULTS: One thousand one hundred fifty-four CRC cases were analyzed, including 781 colon cancer and 373 rectal cancer cases. Nineteen percent of colon cases had family history of CRC in a first-degree relative, compared with 16% of rectal cancer cases. No statistically significant differences between familial and sporadic colon or rectal cancer cases were detected for age, gender, ethnicity, stage, tumor location, histology, tumor grade, or stage-specific treatment rendered. Among colon cancer cases, family history of CRC (versus no family history as a reference group) was associated with improved OS (adjusted hazard ratio, 0.760; 95% confidence interval, 0.580-0.997), but not with CRC-SS (hazard ratio, 0.880; 95% confidence interval, 0.621-1.246). No OS or CRC-SS differences were detected for rectal cancer cases. CONCLUSIONS: CRC cases with family history of the disease have improved overall survival compared with sporadic CRC cases, a finding that is independent of other relevant clinical factors.
BACKGROUND:Colorectal cancer (CRC) family history is a known risk factor for CRC development; however, effects of CRC family history on survival after CRC diagnosis are less well-defined. Our population-based analysis investigates whether familial CRC cases exhibit improved survival compared with sporadic CRC cases. METHODS: Cases enrolled in the University of California Irvine Gene-Environment Study of Familial Colorectal Cancer from 1994 to 1996 were analyzed, with follow-up through December 2006. Cases were categorized as familial or sporadic based on self-reported CRC family history in a first-degree relative. Univariate and multivariate survival analyses with Cox proportional hazards ratios were done for overall survival (OS) and CRC-SS (CRC-SS). RESULTS: One thousand one hundred fifty-four CRC cases were analyzed, including 781 colon cancer and 373 rectal cancer cases. Nineteen percent of colon cases had family history of CRC in a first-degree relative, compared with 16% of rectal cancer cases. No statistically significant differences between familial and sporadic colon or rectal cancer cases were detected for age, gender, ethnicity, stage, tumor location, histology, tumor grade, or stage-specific treatment rendered. Among colon cancer cases, family history of CRC (versus no family history as a reference group) was associated with improved OS (adjusted hazard ratio, 0.760; 95% confidence interval, 0.580-0.997), but not with CRC-SS (hazard ratio, 0.880; 95% confidence interval, 0.621-1.246). No OS or CRC-SS differences were detected for rectal cancer cases. CONCLUSIONS: CRC cases with family history of the disease have improved overall survival compared with sporadic CRC cases, a finding that is independent of other relevant clinical factors.
Authors: D J Peel; A Ziogas; E A Fox; M Gildea; B Laham; E Clements; R D Kolodner; H Anton-Culver Journal: J Natl Cancer Inst Date: 2000-09-20 Impact factor: 13.506
Authors: T Watanabe; T T Wu; P J Catalano; T Ueki; R Satriano; D G Haller; A B Benson; S R Hamilton Journal: N Engl J Med Date: 2001-04-19 Impact factor: 91.245
Authors: P Gervaz; H Bouzourene; J P Cerottini; P Chaubert; J Benhattar; M Secic; S Wexner; J C Givel; B Belin Journal: Dis Colon Rectum Date: 2001-03 Impact factor: 4.585
Authors: Anne C Kirchhoff; Polly A Newcomb; Amy Trentham-Dietz; Hazel B Nichols; John M Hampton Journal: Fam Cancer Date: 2008-03-24 Impact factor: 2.375
Authors: Jason A Zell; Argyrios Ziogas; Leslie Bernstein; Christina A Clarke; Dennis Deapen; Joan A Largent; Susan L Neuhausen; Daniel O Stram; Giske Ursin; Hoda Anton-Culver Journal: Cancer Prev Res (Phila) Date: 2010-06-15
Authors: Jason A Zell; Argyrios Ziogas; Natalia Ignatenko; Jane Honda; Ning Qu; Alexander S Bobbs; Susan L Neuhausen; Eugene W Gerner; Hoda Anton-Culver Journal: Clin Cancer Res Date: 2009-09-29 Impact factor: 12.531
Authors: Jason A Zell; Argyrios Ziogas; Leslie Bernstein; Christina A Clarke; Dennis Deapen; Joan A Largent; Susan L Neuhausen; Daniel O Stram; Giske Ursin; Hoda Anton-Culver Journal: Cancer Date: 2009-12-15 Impact factor: 6.860
Authors: Amanda I Phipps; Dennis J Ahnen; Peter T Campbell; Aung Ko Win; Mark A Jenkins; Noralane M Lindor; Robert Gryfe; John D Potter; Polly A Newcomb Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-06-02 Impact factor: 4.254
Authors: Yoshifumi Baba; Katsuhiko Nosho; Kaori Shima; Ellen Freed; Natsumi Irahara; Juliet Philips; Jeffrey A Meyerhardt; Jason L Hornick; Ramesh A Shivdasani; Charles S Fuchs; Shuji Ogino Journal: Clin Cancer Res Date: 2009-07-07 Impact factor: 12.531
Authors: Nora B Henrikson; Elizabeth M Webber; Katrina A Goddard; Aaron Scrol; Margaret Piper; Marc S Williams; Doris T Zallen; Ned Calonge; Theodore G Ganiats; A Cecile J W Janssens; Ann Zauber; Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Evelyn P Whitlock Journal: Genet Med Date: 2015-01-15 Impact factor: 8.822
Authors: Amit A Negandhi; Angela Hyde; Elizabeth Dicks; William Pollett; Banfield H Younghusband; Patrick Parfrey; Roger C Green; Sevtap Savas Journal: PLoS One Date: 2013-04-23 Impact factor: 3.240